SUBSCRIBE TO TMCnet
TMCnet - World's Largest Communications and Technology Community

TMCNet:  Research and Markets: Discovery Stage Partnering Terms and Agreements in Pharma and Biotech - 2014 Edition

[February 17, 2014]

Research and Markets: Discovery Stage Partnering Terms and Agreements in Pharma and Biotech - 2014 Edition

DUBLIN --(Business Wire)--

Research and Markets (http://www.researchandmarkets.com/research/pkj98s/discovery_stage) has announced the addition of the "Discovery Stage Partnering Terms and Agreements in Pharma and Biotech" report to their offering.

This report provides a detailed understanding and analysis of how and why companies enter discovery stage partnering deals. The majority of deals are where the licensee obtains a right or an option right to license the licensors product or compound. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

Understanding the flexibility of a prospective partner's negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clases, the devil is in the detail in terms of how payments are triggered - contract documents provide this insight where press releases do not.


This report contains over 4,000 links to online copies of actual discovery stage deals and contract documents as submitted to the Securities Exchange Commission by companies and their partners. Contract documents provide the answers to numerous questions about a prospective partner's flexibility on a wide range of important issues, many of which will have a significant impact on each party's ability to derive value from the deal.

The initial chapters of this report provide an orientation of discovery stage deal making and business activities.

Companies Mentioned:

  • Abbott
  • Actavis
  • Bristol-Myers Squibb
  • Celgene
  • Daiichi Sankyo
  • Elan
  • Eli Lilly
  • Fresenius Biotech
  • GE Healthcare
  • GlycArt
  • ImmunoGen
  • Intrexon
  • Johnson & Johnson
  • KaloBios Pharmaceuticals
  • Lpath
  • Lundbeck
  • Macrogenics
  • Merck & Co
  • Novo Nordisk
  • Orbimed Advisors
  • Peregrine Pharmaceuticals
  • Pfizer
  • RIT Oncology
  • Seattle Genetics
  • TrovaGene
  • TTFactor
  • University of Texas
  • Wyeth
  • Xencor
  • ZymoGenetics

For more information visit http://www.researchandmarkets.com/research/pkj98s/discovery_stage

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


[ Back To Technology News's Homepage ]

OTHER NEWS PROVIDERS







Technology Marketing Corporation

800 Connecticut Ave, 1st Floor East, Norwalk, CT 06854 USA
Ph: 800-243-6002, 203-852-6800
Fx: 203-866-3326

General comments: tmc@tmcnet.com.
Comments about this site: webmaster@tmcnet.com.

STAY CURRENT YOUR WAY

© 2014 Technology Marketing Corporation. All rights reserved | Privacy Policy